tiprankstipranks
Trending News
More News >
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market

Concord Biotech Ltd. (CONCORDBIO) Financial Statements

Compare
0 Followers

Concord Biotech Ltd. Financial Overview

Concord Biotech Ltd.'s market cap is currently ₹172.89B. The company's EPS TTM is ₹31.187; its P/E ratio is 52.99; and it has a dividend yield of 0.53%. Concord Biotech Ltd. is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is ₹10.20. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 9.98B₹ 8.53B₹ 7.08B₹ 6.04B₹ 5.12B
Gross Profit₹ 7.53B₹ 6.73B₹ 5.31B₹ 4.84B₹ 3.74B
Operating Income₹ 6.26B₹ 3.27B₹ 2.44B₹ 3.07B₹ 1.94B
EBITDA₹ 4.66B₹ 3.83B₹ 2.97B₹ 3.42B₹ 2.14B
Net Income₹ 3.08B₹ 2.40B₹ 1.75B₹ 2.35B₹ 1.69B
Balance Sheet
Cash & Short-Term Investments₹ 2.86B₹ 1.72B₹ 1.62B₹ 2.01B₹ 456.20M
Total Assets₹ 17.01B₹ 15.14B₹ 13.13B₹ 11.83B₹ 9.41B
Total Debt₹ 97.38M₹ 315.47M₹ 624.93M₹ 892.83M₹ 509.63M
Net Debt₹ -54.05M₹ 280.48M₹ 618.26M₹ 841.39M₹ 53.43M
Total Liabilities₹ 1.74B₹ 2.24B₹ 2.10B₹ 1.83B₹ 1.70B
Stockholders' Equity₹ 15.27B₹ 12.90B₹ 11.03B₹ 9.99B₹ 6.49B
Cash Flow
Free Cash Flow₹ 1.80B₹ 1.01B₹ 519.70M₹ -373.59M₹ -6.23M
Operating Cash Flow₹ 2.65B₹ 2.46B₹ 2.07B₹ 1.67B₹ 1.55B
Investing Cash Flow₹ -1.55B₹ -1.58B₹ -1.12B₹ -1.95B₹ -1.13B
Financing Cash Flow₹ -992.15M₹ -852.19M₹ -1.00B₹ 311.24M₹ -434.16M
Currency in INR

Concord Biotech Ltd. Earnings and Revenue History

Concord Biotech Ltd. Debt to Assets

Concord Biotech Ltd. Cash Flow

Concord Biotech Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis